ACARX
Price
$42.02
Change
-$0.21 (-0.50%)
Updated
Oct 17 closing price
Net Assets
3.22B
RGACX
Price
$84.70
Change
+$0.17 (+0.20%)
Updated
Oct 17 closing price
Net Assets
336.3B
Interact to see
Advertisement

ACARX vs RGACX

Header iconACARX vs RGACX Comparison
Open Charts ACARX vs RGACXBanner chart's image
Alger Capital Appreciation Instl R
Price$42.02
Change-$0.21 (-0.50%)
VolumeN/A
Net Assets3.22B
American Funds Growth Fund of Amer R3
Price$84.70
Change+$0.17 (+0.20%)
VolumeN/A
Net Assets336.3B
ACARX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
ACARX vs. RGACX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACARX is a StrongBuy and RGACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 336B vs. ACARX (3.22B). RGACX pays higher dividends than ACARX: RGACX (0.07) vs ACARX (0.00). ACARX was incepted earlier than RGACX: ACARX (23 years) vs RGACX (23 years). ACARX (1.69) is less costly to investors than RGACX (0.94). ACARX is a more actively managed with annual turnover of: 59.80 vs. RGACX (25.00). ACARX has a lower initial minimum investment than RGACX: ACARX (0) vs RGACX (250). ACARX annual gain was more profitable for investors over the last year : 21.42 vs. RGACX (10.78). RGACX return over 5 years is better than : 37.57 vs. ACARX (6.78).
ACARXRGACXACARX / RGACX
Total Expense Ratio1.690.94180%
Annual Report Gross Expense Ratio1.690.94180%
Fund Existence23 years23 years-
Gain YTD31.02717.419178%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets3.22B336B1%
Annual Yield % from dividends0.000.07-
Returns for 1 year21.4210.78199%
Returns for 3 years97.8970.22139%
Returns for 5 years6.7837.5718%
Returns for 10 years66.9296.3969%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TEMUX17.33N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
FATEX129.96N/A
N/A
Fidelity Advisor Technology M
EMECX13.10N/A
N/A
Ashmore Emerging Markets Equity C
IBARX25.97N/A
N/A
Macquarie Balanced Fund Class R6
GVALX15.05N/A
N/A
Gotham Large Value Institutional